Trial Information
Summary: Eszopiclone for Sleep Disturbance and Nightmares in Post Traumatic Stress Disorder
The Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital is studying medication therapy for the treatment of post-traumatic stress disorder and sleep related problems. Participants in this research study will receive a medical evaluation as well as study related medication over nine weeks and treatment at no cost.
Eligibility Criteria:
1. Must be 18-64 years of age
2. Must not be pregnant or breastfeeding
|
Contact:
Samantha Moshier, Clinical Research Coordin
Massachusetts General Hospital (MGH)
55 Fruit Street
Boston, MA 02114
Telephone: 617-726-3508
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: July 7, 2008 at 3:16:15 PM